ViOptix

What ViOptix does

ViOptix, Inc. is a privately held medical device company founded in 1999 and headquartered in Newark, California, that develops and commercializes proprietary near-infrared spectroscopy (NIRS) tissue oximetry systems for non-invasive, real-time measurement of tissue oxygen saturation (StO2) during and after surgery. The company's technology platform analyzes photon scattering and absorption to determine oxyhemoglobin and deoxyhemoglobin ratios in subcutaneous tissues, delivering quantitative StO2 readings every four seconds. Its product portfolio comprises three FDA-cleared devices: the T.Ox console-based monitoring system with disposable sensors (cleared 2005), the T.Ox Remote Wi-Fi-enabled monitoring extension, and the Intra.Ox handheld tissue oximeter (cleared August 2021) that operates without capital equipment or dye injection. ViOptix sells primarily to plastic and reconstructive surgeons performing microsurgical breast reconstruction and free flap procedures, with secondary use cases in colorectal surgery for anastomotic perfusion assessment. The company targets leading academic medical centers (Beth Israel Deaconess, Cleveland Clinic, Memorial Sloan Kettering, Johns Hopkins, NYU Langone, University of Chicago Medicine) through an enterprise field sales motion supported by free clinical evaluations, peer-reviewed clinical publications, and medical society sponsorships. Revenue is generated through one-time capital equipment sales (T.Ox consoles) plus recurring disposable sensor sales (sterile patches and intraoperative sheaths sold in 5-packs), with quote-based enterprise pricing and multi-year contracts. The company has raised approximately $27.2M in disclosed funding across four rounds between 2004 and 2010, with no subsequent funding events disclosed.

Name

ViOptix

Legal name

ViOptix, Inc.

Website

https://vioptix.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

ViOptix develops FDA-cleared near-infrared spectroscopy tissue oximetry systems that non-invasively measure tissue oxygen saturation in real time for plastic, reconstructive, and colorectal surgeons performing microsurgical procedures at leading hospitals.

Ownership category

akta.pro rank

Product category

Tissue Oximetry Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

akta.pro secondary industries

Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD), Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate) (HLAHAGAI)

Keywords

• Tissue oximetry devices
• Near-infrared spectroscopy
• Surgical monitoring equipment
• Disposable medical sensors
• Non-invasive diagnostics

Headquarters

HQ city

Fremont

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Capital Equipment Sales: Sale of T.Ox Tissue Oximeter console systems (OXY-2-COE-2 Dual Channel Console) to hospitals as capital equipment
2. Disposable Sensor Sales: Recurring revenue from sale of single-use sterile sensors (SP Disposable Small Patch Sensor and SS Disposable Sensor with Silicone Surround). Sold in packages of 5.
3. Intra.Ox Disposable Sheath Sales: Sale of sterile disposable intraoperative sheaths (OXY-2-STH-1-P5) and reusable smart sensors for the Intra.Ox handheld device

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

ViOptix manufactures and sells FDA-cleared proprietary tissue oximetry devices that use near-infrared spectroscopy (NIRS) to non-invasively measure tissue oxygen saturation (StO2) in real time. The product line consists of the T.Ox dual-channel console system with sterile disposable sensors, the T.Ox Remote Wi-Fi monitoring extension, and the Intra.Ox handheld tissue oximeter with reusable smart sensors and sterile sheaths — sold primarily to hospitals and healthcare systems for use in reconstructive microsurgery and other surgical applications.

Product overview

ViOptix provides three FDA-cleared tissue oximetry products utilizing near-infrared spectroscopy (NIRS) technology to measure tissue oxygen saturation (StO2). The T.Ox system serves as the core monitoring platform with a portable console and disposable sensors. T.Ox Remote extends the system with Wi-Fi-based remote monitoring capabilities for smartphones and computers. Intra.Ox is a handheld tissue oximeter designed for point-of-care intraoperative assessment without requiring capital equipment. All three products measure StO2 to assess tissue health during and after surgical procedures, particularly in microsurgery and breast reconstruction.

Differentiator

Problem solved

Functional benefit

Products and services

• T.Ox Tissue Oximeter
• T.Ox Remote
• Intra.Ox Handheld Tissue Oximeter

Quantifiable outcome

• Flap salvage rates increased from 57.7% to 93.75% in microsurgical breast reconstruction
• +5 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered minor and core.

• Breast Reconstruction Awareness (BRA Day)minorGTM or Marketing PartnerViOptix is a proud supporter of National Breast Reconstruction Awareness Day, an initiative promoting education, awareness and access for women considering post-mastectomy breast reconstruction.
• Cleveland CliniccoreStrategic or Co-development PartnerViOptix sponsors a selected resident in Cleveland Clinic's Plastic Surgery Residency and Reconstructive Microsurgery Fellowship program with worldwide reputation and heritage of innovation.
• American Society for Reconstructive Microsurgery (ASRM)minorGTM or Marketing PartnerViOptix funds two travel scholarships for the Women's Microsurgery Group of ASRM, allowing women medical students or residents to experience the ASRM Annual Meeting.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Masimo: Masimo is a leading patient monitoring company specializing in pulse oximetry and non-invasive monitoring technologies. While Masimo's core focus is pulse oximetry rather than tissue oximetry, both companies serve the hospital monitoring market with proprietary optical-based sensing platforms and overlap in clinical decision-making use cases.
• Medtronic (Nellcor): Medtronic acquired Nellcor (pulse oximetry pioneer founded by ViOptix's Executive Chairman Jack Lloyd) and is a major player in patient monitoring including oximetry. As a broad incumbent in patient monitoring with overlapping sensor technology, Medtronic represents both a competitive threat and potential strategic acquirer.
• Edwards Lifesciences: Edwards Lifesciences is a leader in advanced hemodynamic and tissue oximetry monitoring through its FORE-SIGHT cerebral oximetry platform. Edwards competes with ViOptix in tissue/somatic oximetry for surgical and critical care applications with a larger commercial footprint and stronger sales infrastructure.
• Philips Healthcare: Philips is a major patient monitoring incumbent offering a comprehensive suite of bedside and wearable monitoring solutions in hospitals. Philips competes with ViOptix for hospital monitoring budget and decision-maker attention across the perioperative and inpatient care continuum.
• GE HealthCare: GE HealthCare provides a broad portfolio of patient monitoring, anesthesia, and perioperative care solutions used in hospitals globally. GE competes with ViOptix as a multi-modality incumbent that can bundle tissue oximetry alternatives into larger capital equipment contracts.
• ICU Medical (Smiths Medical): ICU Medical (which acquired Smiths Medical) offers a range of medical devices including patient monitoring and infusion systems used in surgical and critical care settings. The company provides overlapping clinical-use equipment in hospital surgical departments.

Direct peers

• Nonin Medical: Nonin Medical manufactures pulse oximeters and regional oximetry sensors using similar optical spectroscopy principles. Both companies target clinical and ambulatory oximetry markets with FDA-cleared devices, and Nonin's regional oximetry products compete with ViOptix's tissue oximetry in adjacent use cases.
• CAS Medical Systems (now part of Natus): CAS Medical Systems (acquired by Natus Medical) produced FORE-SIGHT cerebral/somatic oximetry systems using near-infrared spectroscopy, directly comparable to ViOptix's NIRS tissue oximetry platform for surgical and critical care monitoring applications.

Emerging players

• Stryker (SPY-PHI): Stryker's SPY-PHI fluorescence imaging system provides intraoperative perfusion assessment for reconstructive surgery using ICG angiography. This technology competes directly with ViOptix for surgeon adoption in plastic and reconstructive surgery perfusion assessment.

Regional players

• Hospira / ICU Medical (SedLine, LiDCO): ICU Medical's patient monitoring and hemodynamic monitoring portfolio competes with ViOptix in hospital perioperative settings. The overlap is on hospital monitoring infrastructure where capital budget allocations compete against ViOptix's tissue oximetry capital equipment sales.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/vioptixinc
• Facebookfacebook.com/345713032217482
• LinkedInlinkedin.com/company/vioptix-inc.

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds4 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ViOptix